OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI has acquired Orchestra Bio, a platform that helps drug companies coordinate the work of developing new medicines. The deal gives OpenAI a product aimed[…]
OpenAI has acquired Orchestra Bio, a platform that helps drug companies coordinate the work of developing new medicines. The deal gives OpenAI a product aimed[…]
